Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

Nissan Motor unveiled sweeping new cost cuts, saying it would eliminate 11,000 more jobs and close 7 plants, capping a ...

The company held firm with its full-year profit growth outlook, as the impact of tariffs is expected to be limited. Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is ...

Canadian pipeline operator Enbridge exceeded market estimates for first-quarter profit on Friday, driven in part by higher ...

SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...

SaaS revenue grows 16% (constant currency1 17%), adjusted EBITDA1 margin of 25% Annual recurring revenue2 grows 14% (constant currency1 14%) FY 2025 guidance reiterated after solid first quarter ...